Myeloma UK Publication, intended for UK Audience: Myeloma – An Introduction - Myeloma Essentials
NCCN GUIDELINES FOR PATIENTS: MULTIPLE MYELOMA 2023
What is Multiple Myeloma? www.uptodate.com
Explore MCT: Join us in creating the most comprehensive platform for Myeloma Clinical Trials
Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj - Monoclonal Ab - Immunotherapy
Patient Education: Lenalidomide - Immunomodulatory Agents - IMIDS
Patient Education: Bortezomib (Velcade) - Proteasome Inhibitor
Why is it important to become your own best advocate? HealthTree University Myeloma
What is a Myeloma Specialist Why do I Need one and How do I Find One? HealthTree University Myeloma
The Binding Site: Freelite Overview
Siteman Cancer Center: Autologous stem cell transplant at Siteman Cancer Center
IMF - International Myeloma Foundation: Patient Handbook 2022
PE: CDC Guidelines: How to prevent infections (Sepsis) while getting chemotherapy?
Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S.
National Cancer Institute: Clinical Trials Information for Patients and Caregivers
Dana-Farber's 2022 Multiple Myeloma Patient Symposium - Update on Multiple Myeloma Treatment
How to Prevent Neutropenic Sepsis on Treatment? Know Your ANC (Absolute Neutrophil Count)
You are central to the care team: Be Empowered - IMF Patient & Family Webinar - May 14, 2022
Multiple Myeloma Research Foundation - MMRF - Minimal Residual Disease (MRD)